Shriram Bairagi
Publications by Shriram Bairagi
2 publications found • Active 2015-2020
2020
1 publicationNovel Coronavirus 2019-nCOVID: A Review
The purpose of this article is to provide the information about a newly discovered viral disease called Corona Virus Disease 2019 (COVID-19). This disease brings different types of respiratory tract infections to the body. The article provides basic knowledge about the disease for awareness. This article covers the various aspects of the virus as in structural binding, interaction, adaptation of virus with time, symptoms, causes, diagnosis, treatment and prevention. The awareness regarding this disease is essential because it has no well – defined cause and can happen to any person or animal. This disease can lead to death. Management of patients with COVID-19 begins with the establishment of an accurate diagnosis of disease followed by treatment using an appropriate medication in a manner to suppress the symptoms at first. The goal of therapy is to completely control the symptoms without producing unacceptable medication side effects. The following data contains various images for better understanding. The objective of this paper is only to create awareness and how one can avoid the disease by certain precautions. This article also helps one to understand the symptoms and can give one-self the benefit of the doubt and can cure it by proper consultation.
2015
1 publicationOxyntomodulin, Obestatin and Leptin Potential Weight Reducing Agents: a Review
As obesity remains the center of concern from many decades but yet there is no exact treatment, mostly you have to prefer the surgical method such as gastric bypass, which remains the only therapeutic treatment and the anti-obesity pharmacotherapy remains very limited therefore the priority is to discover or develop more potent drugs. The only potential strategy is to achieve weight loss it can be done by either reducing energy intake or by stimulating anorexigenic signals or by blocking orexegenic signals and to increase energy expenditure. This can be achieved by stimulating the Oxm, peptide PYY, GLP, GLP-1 receptor, and fat cells derived hormone like Leptin and Obestatin these reduces obesity by reducing food intake as seen in mice and humans by stimulating satiety signals, and by regulating the glucose homeostasis, by secreting glucose dependent insulin.
